Nov
DEC
Jan
19
2014
2015
2016
1 captures
19 Dec 15 - 19 Dec 15
Close
Help
Skip to main content
Access brought to you by:
LOCKSS
Login
Search for this keyword
Advanced Search
Main menu
HOME
BROWSE BY CONFERENCE
BROWSE BY DISCIPLINE
-- All Disciplines --
Anesthesiology
Cardiology & Cardiovascular Medicine
Dentistry
Dermatology
Endocrinology, Diabetes & Metabolism
Emergency Medicine & Critical Care
Hematology
Hepatology
Infectious Diseases
Nephrology
Neurology
Nutrition
Obstetrics & Gynecology
Oncology
Ophthalmology
Orthopaedics & Sports Medicine
Psychiatry & Psychology
Pulmonary & Respiratory Medicine
Radiology
Rheumatology
Veterinary Medicine
ABOUT
About Us
International Medical Advisory Board
Reprints
Librarian resources
Contact us
Help
Arrhythmias
Apixaban Superior to Warfarin for Prevention of SSE in Patients with AF: Results from ARISTOTLE
Benefits of Apixaban over Warfarin are Consistent, Irrespective of TTR
Increased Bleeding Risk with Concomitant Use of Antiplatelet Therapy: Dabigatran vs Warfarin
Treating Atrial Fibrillation
Severity of Deficit Strongly Predicts Long-Term Survival among Stroke Survivors
ROCKET-AF: Rivaroxaban Prevents Stroke as Effectively as Warfarin, with Lower Bleeding Risk
No Reduction in Recurrent AF with Omega-3 Fatty Acids
The Role of Newer Anticoagulants in the Treatment of Atrial Fibrillation
Apixaban Reduces Stroke Risk in Patients with AF: Results from the AVERROES Trial
DANPACE: Dual-Chamber Pacing Preferred in Sick Sinus Syndrome
Pages
Previous
Next
1
…
9
10
11
12
13
14
15
16
17